Point72 Europe’s Zimmer Biomet ZBH Stock Holding History

Point72 Europe’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-68,202	Closed	-$7.4M	–	190
2024 Q2	$7.4M	Buy	+68,202	New	+$8.04M	0.61%	56

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Point72 Europe's ZBH Position: Q3 2024 in Review

Point72 Europe sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 68,202 shares — an estimated $7.4M sold.

Point72 Europe first reported a position in ZBH in Q2 2024 and held it in 1 quarter. The position peaked at $7.4M in Q2 2024. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

Point72 Europe reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
Point72 Europe sold 68,202 Zimmer Biomet shares in Q3 2024, an estimated $7.4M.
Point72 Europe first reported a position in Zimmer Biomet in Q2 2024 and held it in 1 quarter.
Point72 Europe's Zimmer Biomet position peaked at $7.4M in Q2 2024.
981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Point72 Europe's 13F filing for Q3 2024, filed 14 Nov 2024.